Results 161 to 170 of about 5,741,783 (179)
Some of the next articles are maybe not open access.
Vimseltinib (Romvimza) for Tenosynovial Giant Cell Tumor
The Medical Letter on Drugs and TherapeuticsVimseltinib (Romvimza – Deciphera), an oral kinase inhibitor, has been approved by the FDA for treatment of symptomatic tenosynovial giant cell tumor in adults for whom surgical resection would cause worsening functional limitation or severe morbidity. The kinase inhibitor pexidartinib (Turalio) was approved for a similar indication in 2019.
openaire +2 more sources
An evaluation of vimseltinib for treatment of tenosynovial giant cell tumors
Expert Review of Anticancer TherapyTenosynovial giant cell tumor (TGCT) is a rare soft tissue neoplasm with aggressive local growth. The disease is driven by excessive CSF1 expression in tumor cells, leading to increased recruitment of monocytes and macrophages, cytokine production, and tumor development. Targeted therapy against CSF1R is an effective treatment approach for unresectable,
Katarzyna, Kisielewska, Piotr, Rutkowski
openaire +2 more sources
Tenosynovial Giant Cell Tumor of the Finger
2023null Joseph E. Judge, MD +2 more
openaire +1 more source
MRI Prediction Model for Tenosynovial Giant Cell Tumor with Risk of Diffuse-type
Academic Radiology, 2023Seul Ki Lee
exaly
Tenosynovial Giant Cell Tumor of the Retropharynx: A Case Report With Literature Review
Ear, Nose and Throat Journal, 2021Feng Liu, Guo Liu
exaly
Diffuse-variant tenosynovial giant cell tumor: A rare and aggressive lesion
Human Pathology, 1994W S Hwang
exaly
Tenosynovial giant-cell tumor arising from the anterior cruciate ligament of the knee
Arthroscopy - Journal of Arthroscopic and Related Surgery, 1996Satoshi Kudo, Yutaka Ōtsuka
exaly